PCMC
IART icon

Planning Capital Management Corporation’s Integra LifeSciences IART Stock Holding History

Planning Capital Management Corporation’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.31K Hold
292
– – ﹤0.01% 506
2024
Q2 		$8.51K Hold
292
– – 0.01% 422
2024
Q1 		$10.4K Buy
+292
New +$11.7K 0.01% 417

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Planning Capital Management Corporation's IART Position: Q3 2024 in Review

Planning Capital Management Corporation held its Integra LifeSciences (IART) position steady in Q3 2024 at 292 shares worth $5.31K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Planning Capital Management Corporation first reported a position in IART in Q1 2024 and has held it in 3 quarters since. The position peaked at $10.4K in Q1 2024. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Planning Capital Management Corporation held 292 shares of Integra LifeSciences worth $5.31K as of Q3 2024.
  • Planning Capital Management Corporation left its Integra LifeSciences share count unchanged in Q3 2024.
  • Integra LifeSciences made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #506 holding.
  • Planning Capital Management Corporation first reported a position in Integra LifeSciences in Q1 2024 and has held it in 3 quarters since.
  • Planning Capital Management Corporation's Integra LifeSciences position peaked at $10.4K in Q1 2024.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.